Tag: CBT > Cannabis DEA: Page 2

International

Bright Green Completes Restructuring Plan, Sets Course on Producing DEA Scheduled Controlled Substances

The company entered into an agreement with the Drug Enforcement Administration to withdraw all cannabis-related renewal applications.

February 24, 2025

Cannabis Rescheduling

NCIA Files Motion With DEA Judge to Consolidate With Rescheduling Participant Absent of Standing

Veteran and medical cannabis advocate Ellen Brown hopes to partner with the National Cannabis Industry Association for the hearing process.

February 13, 2025

Cannabis Rescheduling

DEA Judge Grants Requests From 3 Pro-Cannabis Rescheduling Participants, Says Hearing Up to DEA

Connecticut Office of the Cannabis Ombudsman and The Doc App dropped out, Ellen Brown is on the clock, and attorney Matt Zorn is no longer involved.

February 12, 2025

Cannabis Industry Research

The Man Behind DEA’s Federal Marijuana Scam

DEA Senior Policy Adviser Matthew Strait defied presidential mandates for medical research, MMJ International Holdings claims.

January 28, 2025

Top Stories

Former DEA Special Agent Derek S. Maltz Appointed Acting DEA Administrator

The appointee said in May that if science supports cannabis rescheduling ‘then so be it,’ but that it’s ‘crystal clear’ that ‘the Justice Department hijacked the rescheduling process, placing politics above public safety.’

January 21, 2025

Cannabis Rescheduling

DEA Judge Sends Interlocutory Appeal to Administrator; Recommends All Participants Be Included

The judge asked DEA Administrator Anne Milgram to include all designated participants for the cannabis rescheduling hearing to be part of a briefing schedule.

January 16, 2025

Cannabis Rescheduling

Village Farms International Comments on Delayed Cannabis Rescheduling Process

The hearing’s designated participant views the delay as an imperative administrative step and symbolic win for the industry against a ‘conflicted’ DEA.

January 15, 2025

Cannabis Rescheduling

DEA Judge Grants Interlocutory Appeal, Cancels Cannabis Rescheduling Hearing

The rescheduling proceedings won’t pick up for at least 90 days—if at all—pending a resolution of the appeal to the DEA administrator.

January 14, 2025

Cannabis Rescheduling

Interlocutory Appeal Could Derail Cannabis Rescheduling Hearing

New evidence prompted rescheduling advocates’ second effort to oust the DEA from the hearing; if relief is denied, they will seek the appeal.

January 8, 2025

Industry Headlines

Attorney General, DEA Director, Judge Under Federal Court Summons Over DEA Marijuana Policy

Despite the DEA’s policy, MMJ International is moving forward with the FDA on cannabis drug development for Huntington’s disease.

January 6, 2025

Top Stories

Judge Calls DEA Subpoena Request ‘Blunder,’ Rejects 3 of 4 for Cannabis Rescheduling Hearing

Administrative Law Judge John Mulrooney points out the DEA’s error yet provides the agency another shot at subpoenaing three FDA officials.

December 17, 2024

Industry Headlines

Cannabis Bioscience Fights to Include Longtime Patient as Witness in DEA Rescheduling Hearing

As a designated participant, the company filed a petition to allow testimony from Alexis Bortell, who was diagnosed with intractable epilepsy as a child.

December 16, 2024